<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Fujioka, Ken</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Liraglutide Helps Achieve Significant Weight Loss in Overweight or Obese Patients</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">13-14</style></pages><abstract><style  face="normal" font="default" size="100%">This article reports on results of the Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities study [SCALE; NCT01272219], a 56-week randomized, double-blind, placebo-controlled trial demonstrating the efficacy of liraglutide in inducing and maintaining weight loss, and enhancing health-related quality of life, in 3751 obese or overweight patients with or without prediabetes.</style></abstract><number><style face="normal" font="default" size="100%">47</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>